GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Gross Margin %

Alzinova AB (OSTO:ALZ) Gross Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Alzinova AB's Gross Profit for the three months ended in Sep. 2024 was kr5.77 Mil. Alzinova AB's Revenue for the three months ended in Sep. 2024 was kr0.00 Mil. Therefore, Alzinova AB's Gross Margin % for the quarter that ended in Sep. 2024 was 0.00%.


The historical rank and industry rank for Alzinova AB's Gross Margin % or its related term are showing as below:

OSTO:ALZ' s Gross Margin % Range Over the Past 10 Years
Min: 5797.67   Med: 7360.74   Max: 7360.74
Current: 5797.67


During the past 8 years, the highest Gross Margin % of Alzinova AB was 7360.74%. The lowest was 5797.67%. And the median was 7360.74%.

OSTO:ALZ's Gross Margin % is ranked better than
99.73% of 747 companies
in the Biotechnology industry
Industry Median: 60.58 vs OSTO:ALZ: 5797.67

Alzinova AB had a gross margin of % for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Alzinova AB was 0.00% per year.


Alzinova AB Gross Margin % Historical Data

The historical data trend for Alzinova AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Gross Margin % Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial - - - - 7,360.74

Alzinova AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2,179.26 9,510.00 - -

Competitive Comparison of Alzinova AB's Gross Margin %

For the Biotechnology subindustry, Alzinova AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzinova AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Alzinova AB's Gross Margin % falls into.



Alzinova AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Alzinova AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=19.9 / 0.27
=(Revenue - Cost of Goods Sold) / Revenue
=(0.27 - -19.604) / 0.27
=7,360.74 %

Alzinova AB's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=5.8 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - -5.771) / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Alzinova AB  (OSTO:ALZ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Alzinova AB had a gross margin of % for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Alzinova AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzinova AB Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines